Answers are grounded in this paper and cite their sources.
Background: Machine learning may facilitate the integration of imaging findings and hematological inflammatory indices for clinical classification. This study evaluated whether these variables could discriminate women with established thrombophilia receiving low-molecular-weight heparin (LMWH) from matched women without thrombophilia. Methods: This prospective, single-center, matched case–control study included 160 women undergoing term cesarean delivery: 80 with established thrombophilia receiving prophylactic LMWH and 80 age- and parity-matched controls without thrombophilia. The Postpartum Uterine Ultrasonographic Scale (PUUS) was assessed 24–48 h after delivery, and 11 hematological inflammatory indices were derived from complete blood counts obtained within 24 h before delivery. Five supervised machine-learning algorithms were evaluated: elastic-net logistic regression, random forest, XGBoost, support vector machine with a radial basis function kernel, and multilayer perceptron. Model discrimination was assessed using the area under the receiver operating characteristic curve (AUC), with internal bootstrap-based assessment of optimism and model-selection effects. Results: PUUS scores differed between groups, with PUUS ≥ 1 observed in 32.5% of women with thrombophilia and 13.8% of controls (odds ratio [OR] 3.02, 95% confidence interval [CI] 1.38–6.61; p = 0.005). After adjustment for multiple comparisons, NLPR, IIC, NLR, PLR, SII, SIRI, and AISI differed significantly between groups. Among the five evaluated algorithms, XGBoost achieved the highest observed AUC in the 32-participant hold-out evaluation set (0.938, 95% CI 0.826–0.989), with 90.6% accuracy, 93.8% sensitivity, and 87.5% specificity. Five machine-learning algorithms were evaluated to explore the discrimination between women with LMWH-treated thrombophilia and matched controls without thrombophilia. However, the original analytical dataset and computational outputs were unavailable for independent verification. Consequently, the comparative performance of the algorithms and the previously reported AUC estimates could not be independently confirmed. Conclusions: Machine learning integrating postpartum uterine ultrasonography and hematological inflammatory indices showed promising discrimination between women with LMWH-treated, established thrombophilia and matched controls in this single-center cohort. However, thrombophilia status and LMWH exposure were completely confounded, and the small hold-out evaluation set and lack of external validation limit the interpretation of model performance. The findings should be considered a methodological proof-of-concept rather than evidence of a validated diagnostic or screening tool for untreated or previously undiagnosed thrombophilia. Independent multicenter validation in populations that permit separation of disease-related and treatment-related effects is required before clinical application can be considered.
No takes yet. Share an insight, caveat, or question.
Toma et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: